AXP vs CABA · P/E 20, rev $21.73B vs $143.9M cap
American Express Company (AXP) versus Cabaletta Bio Inc (CABA) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
CABA does not have a complete income-statement cache yet.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. CABA currently screens at market cap $143.9M.
Not investment advice. Open the AXP and CABA stock pages for the full models.
Not investment advice.